NCT05161819 Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder
| NCT ID | NCT05161819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Somatic Symptom Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-08-29 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2022-08-29 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.
Eligibility Criteria
Inclusion Criteria: * Patient with somatic symptom disorder (confirmed by psychiatrists) * Age 20-70 Exclusion Criteria: * Having psychotic symptoms or cognitive impairment * Having potentially lethal illness * Using cardiac pacemakers or defibrillators * Currently pregnant or having plans to become pregnant within the next three months * Received rTMS treatment within three months * Cannot read the questionnaires by oneself * Having to take the following medications persistently: bupropion \>300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline
Contact & Investigator
Wei-Lieh Huang, MD, PhD
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT05161819 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Somatic Symptom Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05161819 currently recruiting?
Yes, NCT05161819 is actively recruiting participants. Contact the research team at weiliehhuang@gmail.com for enrollment information.
Where is the NCT05161819 trial being conducted?
This trial is being conducted at Douliu, Taiwan.
Who is sponsoring the NCT05161819 clinical trial?
NCT05161819 is sponsored by National Taiwan University Hospital. The principal investigator is Wei-Lieh Huang, MD, PhD at National Taiwan University Hospital. The trial plans to enroll 30 participants.